51 Followers on Owler

Morphic

is a Massachusetts-based biopharmaceutical company that develops oral integrin therapies for the treatment of autoimmune, cardiovascular, and metabolic diseases... Read more
OverviewCompetitorsFundingNews & Insights

Morphic

is a Massachusetts-based biopharmaceutical company that develops oral integrin therapies for the treatment of autoimmune, cardiovascular, and metabolic diseases... Read more
Morphic President & CEO: Praveen Tipirneni

President & CEO

Praveen Tipirneni

CEO Approval Rating

90/100

2015

PublicAcquired by Eli Lilly & Co.NASDAQMORF

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals
8000 NAICS listing

Annual Revenue
$ < 1M
Employees
100
Funding
$597.5M

News

Acquisition
Jul 08, 2024
Seeking Alpha
Morphic Was acquired by Eli Lilly & Co. for $3.2B

Morphic Competitors

1AbbVie
2TEVA
3Biogen
4Protagonist
5Galectin
6Pfizer
7Indalo Therapeutics
8Blade Therapeutics
9Xenetic Biosciences
10GlycoMimetics
Unlock 14 + competitors

Trending Companies